Vestipitant 28-day Tolerance Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This study is a 28-day polysomnographic and subjective assessment of oral Vestipitant 15mg/day for treatment of Primary Insomnia in adults outpatients.
Epistemonikos ID: 2897c571fef1cca146449730d1e5c79b43db549a
First added on: May 05, 2024